By Jody Godoy ( June 2, 2015, 7:51 PM EDT) -- A proposed class of consumers who claim that Eli Lilly & Co. concealed the withdrawal risks associated with its antidepressant Cymbalta filed anew for class certification in California court on Monday, using a more "traditional" damages model after a judge shot down its first try....
Law360 is on it, so you are, too.
A Law360 subscription puts you at the center of fast-moving legal issues, trends and developments so you can act with speed and confidence. Over 200 articles are published daily across more than 60 topics, industries, practice areas and jurisdictions.
A Law360 subscription includes features such as
- Daily newsletters
- Expert analysis
- Mobile app
- Advanced search
- Judge information
- Real-time alerts
- 450K+ searchable archived articles
And more!
Experience Law360 today with a free 7-day trial.